Search Results - "Polak, Lenka"

Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies by Domingos-Pereira, Sonia, Sathiyanadan, Karthik, Polak, Lenka, Haefliger, Jacques-Antoine, Schmittnaegel, Martina, Ries, Carola H, Jichlinski, Patrice, Roth, Beat, Derré, Laurent, Nardelli-Haefliger, Denise

“…Bacillus Calmette-Guérin (BCG) instillations for the treatment of non-muscle-invasive bladder cancer patients can result in significant side effects and…”
Get full text

Type 2 innate lymphoid cells are not involved in mouse bladder tumor development by Schneider, Anna K, Domingos-Pereira, Sonia, Cesson, Valérie, Polak, Lenka, Fallon, Padraic G, Zhu, Jinfang, Roth, Beat, Nardelli-Haefliger, Denise, Derré, Laurent

“…Therapies for bladder cancer patients are limited by side effects and failures, highlighting the need for novel targets to improve disease management. Given…”
Get full text

878 Novel microbial immunotherapy approach for the treatment of bladder cancer by Glanville, Nicholas, Oke, Tobi, Domingos-Pereira, Sonia, Polak, Lenka, Nardelli-Haefliger, Denise, Deban, Livija

“…BackgroundMicrobial immunotherapy, in the form of intravesical Bacillus Calmette-Guérin (BCG), is the standard-of-care for non-muscle invasive bladder cancer…”
Get full text

Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential by Derré, Laurent, Lucca, Ilaria, Cesson, Valérie, Bohner, Perrine, Crettenand, Francois, Rodrigues-Dias, Sonia-Cristina, Dartiguenave, Florence, Masnada, Audrey, Teixeira-Pereira, Carla, Benmerzoug, Sulayman, Chevalier, Mathieu F, Domingos-Pereira, Sonia, Nguyen, Sylvain, Polak, Lenka, Schneider, Anna K, Jichlinski, Patrice, Roth, Beat, Nardelli-Haefliger, Denise

“…BackgroundStandard of care treatment of non-muscle invasive bladder cancer (NMIBC) with intravesical Bacillus Calmette Guérin (BCG) is associated with side…”
Get full text

Intravesical Ty21a Treatment of Non–muscle-invasive Bladder Cancer Shows a Good Safety Profile by Lucca, Ilaria, Derré, Laurent, Cesson, Valérie, Bohner, Perrine, Crettenand, François, Rodrigues-Dias, Sonia, Dartiguenave, Florence, Masnada, Audrey, Texeira-Pereira, Carla, Benmerzoug, Sulayman, Chevalier, Mathieu, Domingos-Pereira, Sonia, Nguyen, Sylvain, Polak, Lenka, Schneider, Anna, Roth, Beat, Jichlinski, Patrice, Nardelli-Haefliger, Denise

“…Standard-of-care immunotherapy for non–muscle-invasive bladder cancer (NMIBC) with intravesical Bacillus Calmettte-Guérin (BCG) is associated with adverse…”
Get full text

Abstract 2462: Live attenuated Salmonella ZH9 as novel microbial immunotherapy for the treatment of bladder cancer by Glanville, Nicholas, Oke, Oluwatobiloba, Prevosto, Claudia, Sevko, Alexandra, Scott, Andrew, Domingos-Pereira, Sonia, Polak, Lenka, Nardelli-Haefliger, Denise, Deban, Livija

“…Microbial immunotherapy with Bacillus Calmette-Guérin (BCG) has been the standard-of-care for non-muscle invasive bladder cancer (NMIBC) for over 30 years…”
Get full text

Insights into Mobile Genetic Elements of the Biocide-Degrading Bacterium Pseudomonas nitroreducens HBP-1 by Carraro, Nicolas, Sentchilo, Vladimir, Polák, Lenka, Bertelli, Claire, van der Meer, Jan Roelof

“…The sewage sludge isolate HBP-1 was the first bacterium known to completely degrade the fungicide 2-hydroxybiphenyl. PacBio and Illumina whole-genome…”
Get full text